Clinical and Experimental Nephrology

, Volume 22, Issue 5, pp 1150–1156 | Cite as

Visit-to-visit blood pressure variability in children and adolescents with renal disease

  • Hisayo Fujita
  • Seiji Matsuoka
  • Midori AwazuEmail author
Original article



Increase in blood pressure (BP) variability (BPV) is associated with cardiovascular events, target organ damage, and arterial stiffness in adults. We previously reported that 24-h BPV may be associated with arterial stiffness and underlie white-coat hypertension (WCH). In this study, we examined whether visit-to-visit variability (VVV) could predict WCH and whether VVV correlated with eGFR, eGFR slope, and albuminuria/proteinuria in children and adolescents with renal diseases.


VVV was determined as average real variability of office BP measurements between visits, and 24-h BPV as the standard deviation of 24-h ambulatory BP. In 35 renal patients (25 boys and 10 girls, 7–18 years of age), divided into normotension (NT), WCH, and hypertension (HTN), the relationships between VVV and 24-h BPV and VVV in each BP category were studied. In separate 48 renal patients (24 boys and 24 girls, 2–18 years of age), the correlation between VVV and eGFR, eGFR slope, urine albumin or protein excretion was examined.


Systolic VVV was significantly correlated with systolic office BP index. There was no correlation between VVV and 24-h BPV or 24-h pulse pressure. In addition, VVV was not different among NT, WCH, and HTN. Systolic VVV was significantly negatively correlated with eGFR but not with eGFR slope, albuminuria, or proteinuria. A cut-off value of systolic VVV for detecting eGFR < 60 ml/min per 1.73 m2 was 8.5.


VVV could not predict WCH. Systolic VVV correlated with eGFR but not with eGFR slope, albuminuria/proteinuria. Increased VVV could be a marker of decreased eGFR.


Visit-to-visit variability Blood pressure variability Average real variability Children eGFR Urinary albumin-to-creatinine ratio 



Ambulatory blood pressure


Average real variability


Ambulatory blood pressure monitoring


Blood pressure


Blood pressure variability






Receiver operating characteristic


Target organ damage


White-coat hypertension


Visit-to-visit variability


Compliance with ethical standards

Conflict of interest

All authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national ethical guidelines for medical and health research involving human subjects and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was not obtained but the option of opting out was provided as approved by the ethics committee at Keio University School of Medicine.


  1. 1.
    Fujita H, Matsuoka S, Awazu M. White-coat and reverse white-coat effects correlate with 24-h pulse pressure and systolic blood pressure variability in children and young adults. Pediatr Cardiol. 2016;37:345–52.CrossRefGoogle Scholar
  2. 2.
    Masugata H, Senda S, Murao K, et al. Visit-to-visit variability in blood pressure over a 1-year period is a marker of left ventricular diastolic dysfunction in treated hypertensive patients. Hypertens Res. 2011;34:846–50.CrossRefGoogle Scholar
  3. 3.
    Kilpatrick ES, Rigby AS, Atkin SL. The role of blood pressure variability in the development of nephropathy in type 1 diabetes. Diabetes Care. 2010;33:2442–7.CrossRefGoogle Scholar
  4. 4.
    Yokota K, Fukuda M, Matsui Y, et al. Impact of visit-to-visit variability of blood pressure on deterioration of renal function in patients with non-diabetic chronic kidney disease. Hypertens Res. 2013;36:151–7.CrossRefGoogle Scholar
  5. 5.
    Brickman AM, Reitz C, Luchsinger JA, et al. Long-term blood pressure fluctuation and cerebrovascular disease in an elderly cohort. Arch Neurol. 2010;67:564–9.CrossRefGoogle Scholar
  6. 6.
    Tedla YG, Yano Y, Carnethon M, et al. Association between long-term blood pressure variability and 10-Year progression in arterial stiffness: the multiethnic study of atherosclerosis. Hypertension. 2017;69:118–27.CrossRefGoogle Scholar
  7. 7.
    Rothwell PM, Howard SC, Dolan E, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010;375:895–905.CrossRefGoogle Scholar
  8. 8.
    Wang J, Shi X, Ma C, et al. Visit-to-visit blood pressure variability is a risk factor for all-cause mortality and cardiovascular disease: a systematic review and meta-analysis. J Hypertens. 2017;35:10–7.CrossRefGoogle Scholar
  9. 9.
    Diaz KM, Tanner RM, Falzon L, et al. Visit-to-visit variability of blood pressure and cardiovascular disease and all-cause mortality: a systematic review and meta-analysis. Hypertension. 2014;64:965–82.CrossRefGoogle Scholar
  10. 10.
    Chen W, Srinivasan SR, Ruan L, et al. Adult hypertension is associated with blood pressure variability in childhood in blacks and whites: the Bogalusa Heart Study. Am J Hypertens. 2011;24:77–82.CrossRefGoogle Scholar
  11. 11.
    Yano Y, Ning H, Allen N, et al. Long-term blood pressure variability throughout young adulthood and cognitive function in midlife: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Hypertension. 2014;64:983–8.CrossRefGoogle Scholar
  12. 12.
    Lande MB, Mendley SR, Matheson MB, et al. Association of blood pressure variability and neurocognition in children with chronic kidney disease. Pediatr Nephrol. 2016;31:2137–44.CrossRefGoogle Scholar
  13. 13.
    Sethna CB, Meyers KEC, Mariani LH, et al. Blood pressure and visit-to-visit blood pressure variability among individuals with primary proteinuric glomerulopathies novelty and significance. Hypertension. 2017;70:315–23.CrossRefGoogle Scholar
  14. 14.
    National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114:555–76.CrossRefGoogle Scholar
  15. 15.
    Imai Y, Sasaki S, Minami N, et al. The accuracy and performance of the A&D TM 2421,a new ambulatory blood pressure monitoring device based on the cuff-oscillometric method and the Korotkoff sound technique. Am J Hypertens. 1992;5:719–26.CrossRefGoogle Scholar
  16. 16.
    O’Sullivan JJ, Derrick G, Griggs PE, et al. Validation of the Takeda 2421 ambulatory blood pressure monitor in children. J Med Eng Technol. 1998;22:101–5.CrossRefGoogle Scholar
  17. 17.
    Wühl E, Witte K, Soergel M, et al. Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens. 2002;20:1995–2007.CrossRefGoogle Scholar
  18. 18.
    Flynn JT, Kaelber DC, Baker-Smith CM, et al. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics. 2017. CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Sorof JM, Poffenbarger T, Franco K, et al. Evaluation of white coat hypertension in children: importance of the definitions of normal ambulatory blood pressure and the severity of casual hypertension. Am J Hypertens. 2001;14:855–60.CrossRefGoogle Scholar
  20. 20.
    Levitan EB, Kaciroti N, Oparil S, et al. Relationships between metrics of visit-to-visit variability of blood pressure. J Hum Hypertens. 2013;27:589–93.CrossRefGoogle Scholar
  21. 21.
    Uemura O, Nagai T, Ishikura K, et al. Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease. Clin Exp Nephrol. 2014;18:626–33.CrossRefGoogle Scholar
  22. 22.
    Yano Y. Visit-to-visit blood pressure variability-what is the current challenge? Am J Hypertens. 2017;30:112–4.CrossRefGoogle Scholar
  23. 23.
    Muntner P, Shimbo D, Diaz KM, et al. Low correlation between visit-to-visit variability and 24-h variability of blood pressure. Hypertens Res. 2013;36:940–6.CrossRefGoogle Scholar
  24. 24.
    Parati G, Ochoa JE, Lombardi C, et al. Assessment and management of blood-pressure variability. Nat Rev Cardiol. 2013;10:143–55.CrossRefGoogle Scholar
  25. 25.
    Muntner P, Joyce C, Levitan EB, et al. Reproducibility of visit-to-visit variability of blood pressure measured as part of routine clinical care. J Hypertens. 2011;29:2332–8.CrossRefGoogle Scholar
  26. 26.
    Kang IS, Pyun WB, Shin J, et al. Higher blood pressure variability in white coat hypertension; from the Korean ambulatory blood pressure monitoring registry. Korean Circ J. 2016;46:365–73.CrossRefGoogle Scholar
  27. 27.
    Gijon-Conde T, Graciani A, Lopez-Garcia E, et al. Short-term variability and nocturnal decline in ambulatory blood pressure in normotension, white-coat hypertension, masked hypertension and sustained hypertension: a population-based study of older individuals in Spain. Hypertens Res. 2017;40:613–9.CrossRefGoogle Scholar
  28. 28.
    Hussein WF, Chang TI. Visit-to-visit variability of systolic blood pressure and cardiovascular disease. Curr Hypertens Rep. 2015;17:14.CrossRefGoogle Scholar
  29. 29.
    Muntner P, Shimbo D, Tonelli M, et al. The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994. Hypertension. 2011;57:160–6.CrossRefGoogle Scholar
  30. 30.
    Diaz KM, Feairheller DL, Sturgeon KM, et al. Increased nitric oxide and attenuated diastolic blood pressure variability in african americans with mildly impaired renal function. Int J Hypertens. 2011;2010:137206.PubMedPubMedCentralGoogle Scholar
  31. 31.
    Kawai T, Ohishi M, Kamide K, et al. The impact of visit-to-visit variability in blood pressure on renal function. Hypertens Res. 2012;35:239–43.CrossRefGoogle Scholar
  32. 32.
    Parati G, Liu X, Ochoa JE. Clinical relevance of visit-to-visit blood pressure variability: impact on renal outcomes. J Hum Hypertens. 2014;28:403–9.CrossRefGoogle Scholar
  33. 33.
    Yano Y, Fujimoto S, Kramer H, et al. Long-term blood pressure variability, new-onset diabetes mellitus, and new-onset chronic kidney disease in the Japanese general population. Hypertension. 2015;66:30–6.CrossRefGoogle Scholar
  34. 34.
    McMullan CJ, Lambers Heerspink HJ, Parving HH, et al. Visit-to-visit variability in blood pressure and kidney and cardiovascular outcomes in patients with type 2 diabetes and nephropathy: a post hoc analysis from the RENAAL study and the Irbesartan Diabetic Nephropathy Trial. Am J Kidney Dis. 2014;64:714–22.CrossRefGoogle Scholar
  35. 35.
    McMullan CJ, Bakris GL, Phillips RA, et al. Association of BP variability with mortality among African Americans with CKD. Clin J Am Soc Nephrol. 2013;8:731–8.CrossRefGoogle Scholar
  36. 36.
    Nakano C, Morimoto S, Nakahigashi M, et al. The relationships between visit-to-visit blood pressure variability and renal and endothelial function in chronic kidney disease. Hypertens Res. 2015;38:193–8.CrossRefGoogle Scholar
  37. 37.
    Lasserson DS, Scherpbier de Haan N, de Grauw W, et al. What is the relationship between renal function and visit-to-visit blood pressure variability in primary care? Retrospective cohort study from routinely collected healthcare data. BMJ Open. 2016;6:e010702.CrossRefGoogle Scholar
  38. 38.
    Whelton PK, Pollock BD. Is it time to employ a measure of visit-to-visit variability in clinical practice? Hypertension. 2017;70:227–8.CrossRefGoogle Scholar
  39. 39.
    Kollias A, Stergiou GS, Kyriakoulis KG, et al. Treating visit-to-visit blood pressure variability to improve prognosis: is amlodipine the drug of choice? Hypertension. 2017;70:862–6.CrossRefGoogle Scholar

Copyright information

© Japanese Society of Nephrology 2018

Authors and Affiliations

  1. 1.Department of PediatricsTokyo Medical CenterTokyoJapan
  2. 2.Matsuoka ClinicYokohamaJapan
  3. 3.Department of PediatricsKeio University School of MedicineTokyoJapan

Personalised recommendations